Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosis
- 1 January 2010
- journal article
- other
- Published by Springer Science and Business Media LLC in Acta Neuropathologica
- Vol. 119 (4), 509-511
- https://doi.org/10.1007/s00401-009-0632-y
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Diagnostic Use ofIDH1/2Mutation Analysis in Routine Clinical Testing of Formalin-Fixed, Paraffin-Embedded Glioma TissuesJournal of Neuropathology and Experimental Neurology, 2009
- IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomasNeuro-Oncology, 2009
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomasActa Neuropathologica, 2009
- IDH1 Mutations Are Early Events in the Development of Astrocytomas and OligodendrogliomasThe American Journal of Pathology, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- IDH1mutations at residue p.R132 (IDH1R132) occur frequently in high-grade gliomas but not in other solid tumorsHuman Mutation, 2008
- Analysis of the IDH1 codon 132 mutation in brain tumorsActa Neuropathologica, 2008
- An Integrated Genomic Analysis of Human Glioblastoma MultiformeScience, 2008
- The p53 Gene and Protein in Human Brain TumorsJournal of Neuropathology and Experimental Neurology, 1994
- An immunohistochemical study of p53 and proliferating cell nuclear antigen expression in progressive multifocal leukoencephalopathyActa Neuropathologica, 1994